Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-κB and IκB in renal cortex of streptozotoxin-induced diabetic rats

Journal of Ethnopharmacology

Volumn 114, Issue 3, 2007, Pages 387-392

  Zhang, Ying Wen ^a   Wu, Chao Yan ^a   Cheng, Juei Tang ^b  

^a WUHAN UNIVERSITY   (China)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Astragalus polysaccharide; Diabetic nephropathy; Inhibitor protein of nuclear factor B (I B); Nuclear factor B (NF B)

Indexed keywords

ASTRAGALUS MEMBRANACEUS EXTRACT; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DECUBITUS; DIABETIC NEPHROPATHY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IMMOBILIZATION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MASS; KYPHOSIS; LETHARGY; LIPID BLOOD LEVEL; MALE; MICROALBUMINURIA; NONHUMAN; POLYDIPSIA; POLYURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; SYMPTOMATOLOGY; WEIGHT REDUCTION;

ANIMALS; ASTRAGALUS PLANT; BENZAZEPINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; I-KAPPA B KINASE; KIDNEY CORTEX; MALE; NF-KAPPA B; PHYTOTHERAPY; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STREPTOZOCIN;

ASTRAGALUS MEMBRANACEUS; RATTUS;

EID: 35648986644     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.08.024     Document Type: Article

References (36)

1. Auwardt R.B., Mudge S.J., Chen C., and Power D.A. Inhibition with antisense oligonucleotide suggests that IkappaB-alpha does not form a negative autoregulatory loop for NF-kappaB in mesangial cells. Experimental Nephrology 8 (2000) 144-151
2. Auwardt R.B., Mudge S.J., Chen C.G., and Power D.A. Regulation of nuclear factor kappaB by corticosteroids in rat mesangial cells. Journal of American Society of Nephrology 9 (1998) 1620-1628
3. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. The New England Journal of Medicine 336 (1997) 1066-1071
4. Bedir E., Pugh N., Calis I., Pasco D.S., and Khan I.A. Immunostimulatory effects of cycloartane-type triterpene glycosides from Astragalus species. Biological and Pharmaceutical Bulletin 23 (2000) 834-837
5. Bohle A., Wehrmann M., Bogenschutz O., Batz C., Muller C.A., and Muller G.A. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathology, Research and Practice 187 (1991) 251-259
6. Burnier M., and Zanchi A. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes. Journal of Hypertension 24 (2006) 11-25
7. Cao C.C., Ding X.Q., Ou Z.L., Liu C.F., Li P., Wang L., and Zhu C.F. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats. Zhonghua Yi Xue Za Zhi 83 (2003) 1597-1602
8. Cooper M.E., Gilbert R.E., and Epstein M. Pathophysiology of diabetic nephropathy. Metabolism 47 (1998) 3-6
9. Galkina E., and Ley K. Leukocyte recruitment and vascular injury in diabetic nephropathy. Journal of American Society of Nephrology 17 (2006) 368-377
10. Gomez-Garre D., Largo R., Tejera N., Fortes J., Manzarbeitia F., and Egido J. Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 37 (2001) 1171-1178
11. Guijarro C., and Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney International 59 (2001) 415-424
12. Hofmann M.A., Schiekofer S., Kanitz M., Klevesath M.S., Joswig M., Lee V., Morcos M., Tritschler H., Ziegler R., Wahl P., et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21 (1998) 1310-1316
13. Iwamoto M., Mizuiri S., Arita M., and Hemmi H. Nuclear factor-kappaB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy. The Tohoku Journal of Experimental Medicine 206 (2005) 163-171
14. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Current Opinion in Cell Biology 9 (1997) 240-246
15. Lal M.A., Brismar H., Eklof A.C., and Aperia A. Role of oxidative stress in advanced glycation end product-induced mesangial cell activation. Kidney International 61 (2002) 2006-2014
16. Lee K.Y., and Jeon Y.J. Macrophage activation by polysaccharide isolated from Astragalus membranaceus. International Immunopharmacology 5 (2005) 1225-1233
17. Lee Y.J., and Han H.J. Effect of adenosine triphosphate in renal ischemic injury: involvement of NF-kappaB. Journal of Cellular Physiology 204 (2005) 792-799
18. Li R.J., Qiu S.D., Chen H.X., Tian H., and Wang H.X. The immunotherapeutic effects of Astragalus polysaccharide in type 1 diabetic mice. Biological and Pharmaceutical Bulletin 30 (2007) 470-476
19. Li S., Zhang Y., and Zhao J. Preparation and suppressive effect of Astragalus polysaccharide in glomerulonephritis rats. International Immunopharmacology 7 (2007) 23-28
20. Liu Z.Q., Li Q.Z., and Qin G.J. Effect of Astragalus injection on platelet function and plasma endothelin in patients with early stage diabetic nephropathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 21 (2001) 274-276
21. Mezzano S., Aros C., Droguett A., Burgos M.E., Ardiles L., Flores C., Schneider H., Ruiz-Ortega M., and Egido J. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrology Dialysis Transplantation 19 (2004) 2505-2512
22. Mohamed A.K., Bierhaus A., Schiekofer S., Tritschler H., Ziegler R., and Nawroth P.P. The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10 (1999) 157-167
23. Navarro J.F., and Mora C. Role of inflammation in diabetic complications. Nephrology Dialysis Transplantation 20 (2005) 2601-2604
24. Ruperez M., Sanchez-Lopez E., Blanco-Colio L.M., Esteban V., Rodriguez-Vita J., Plaza J.J., Egido J., and Ruiz-Ortega M. The Rho-kinase pathway regulates angiotensin II-induced renal damage. Kidney International Supplement (2005) S39-S45
25. Shao B.M., Xu W., Dai H., Tu P., Li Z., and Gao X.M. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochemical and Biophysical Research Communications 320 (2004) 1103-1111
26. Strippoli G.F., Craig M., and Craig J.C. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews (2005) (CD004136)
27. Toda S., and Shirataki Y. Inhibitory effects of Astragali Radix, a crude drug in Oriental medicines, on lipid peroxidation and protein oxidative modification by copper. Journal of Ethnopharmacology 68 (1999) 331-333
28. Toda S., Yase Y., and Shirataki Y. Inhibitory effects of Astragali Radix, crude drug in Oriental medicines on lipid peroxidation and protein oxidative modification of mouse brain homogenate by copper. Phytotherapy Research 14 (2000) 294-296
29. Wajant H. TRAIL and NFkappaB signalling-a complex relationship. Vitamins and Hormones 67 (2004) 101-132
30. Wu Y., Ou-Yang J.P., Wu K., Wang Y., Zhou Y.F., and Wen C.Y. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. Acta Pharmacologica Sinica 26 (2005) 345-352
31. Yin X., Zhang Y., Wu H., Zhu X., Zheng X., Jiang S., Zhuo H., Shen J., Li L., and Qiu J. Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats. Journal of Pharmacological Sciences 95 (2004) 256-266
32. Yin X.X., Zhang Y.D., Shen J.P., Wu H.W., Zhu X., Li L.M., Qiu J., Jiang S.J., and Zheng X.G. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats. Acta Pharmacologica Sinica 26 (2005) 721-728
33. Yin X., Zhang Y., Yu J., Zhang P., Shen J., Qiu J., Wu H., and Zhu X. The antioxidative effects of Astragalus saponin I protect against development of early diabetic nephropathy. Journal of Pharmacological Sciences 101 (2006) 166-173
34. Yuan C.H., Liu Y.F., and Cheng Y. Experimental study on effect of Astragalus extractum on canine isolated kidney during hypothermia perfusion and preservation. Zhongguo Zhong Xi Yi Jie He Za Zhi 23 (2003) 291-293
35. Zhang W.J., Hufnagl P., Binder B.R., and Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thrombosis and Haemostasis 90 (2003) 904-914
36. Ziyadeh F.N. Mediators of diabetic renal disease: the case for tgf-Beta as he major mediator. Journal of the American Society of Nephrology 15 (2004) S55-S57